ACE2 and COVID-19: In animal cell lines, C. sativa has been verified to reduce the expression levels of IL-6, IL-8, C-C motif chemokine ligands (CCLs) 2 and 7, and ACE2, suggesting that it may be a valuable contributor to existing anti-inflammatory regimens for the management of COVID-19 [145].